These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 510142)

  • 1. Evaluation of a portable insulin infusion pump for outpatient management of brittle diabetes.
    Kitabchi AE; Fisher JN; Burghen GA; Gaylord MS; Blank NM
    Diabetes Care; 1979; 2(5):421-4. PubMed ID: 510142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term, ambulatory, subcutaneous insulin infusion versus multiple daily injections in brittle diabetic patients.
    Barbosa J; Menth L; Eaton J; Sutherland D; Freier EF; Najarian J
    Diabetes Care; 1981; 4(2):269-74. PubMed ID: 7011745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes.
    Selam JL; Slingeneyer A; Hedon B; Mares P; Beraud JJ; Mirouze J
    Diabetes Care; 1983; 6(2):105-11. PubMed ID: 6406198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved control in diabetes with continuous subcutaneous insulin infusion.
    Schiffrin A; Colle E; Belmonte M
    Diabetes Care; 1980; 3(6):643-9. PubMed ID: 7004811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system.
    Tamborlane WV; Sherwin RS; Genel M; Felig P
    Am J Med; 1980 Feb; 68(2):190-6. PubMed ID: 6986766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brittle diabetes: long-term control with a portable, continuous, intravenous insulin infusion system.
    Bayliss J
    Br Med J (Clin Res Ed); 1981 Nov; 283(6301):1207-9. PubMed ID: 6797511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive conventional and insulin pump therapies in adult type I diabetes. A crossover study.
    Nathan DM; Lou P; Avruch J
    Ann Intern Med; 1982 Jul; 97(1):31-6. PubMed ID: 7046554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood sugar control in diabetics with the insulin pump. Comparison with discontinuous injections].
    Sudre Y; Abadie JC; Marechaud R; Rossi F; Gouet D; Queron B
    Sem Hop; 1982 Sep; 58(32):1801-4. PubMed ID: 6291163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin therapy by subcutaneous infusion using a portable pump. A simple method to stabilize brittle diabetics (author's transl)].
    Berger W; Schwarz U; Kaegi E; Keller U; Viollier E
    Schweiz Rundsch Med Prax; 1979 Dec; 68(49):1620-9. PubMed ID: 397488
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement of high-density lipoprotein-cholesterol levels. Ambulatory type I diabetics treated with the subcutaneous insulin pump.
    Falko JM; O'Dorisio TM; Cataland S
    JAMA; 1982 Jan; 247(1):37-9. PubMed ID: 7031287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
    Pickup JC; Home PD; Bilous RW; Keen H; Alberti KG
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):347-50. PubMed ID: 6780019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-loop device Microjet MC 2 improves unstable diabetes, lowers the daily insulin requirement and reduces the excursions of plasma free insulin levels: comparison with a traditional intensive treatment.
    Micossi P; Raggi U; Dosio F; Scavini M; Bertin A; Pozza G
    J Endocrinol Invest; 1983 Jun; 6(3):189-94. PubMed ID: 6352793
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of insulin-dependent diabetes with portable miniaturized infusion systems.
    Hepp KD; Renner R; Piwernetz K; Mehnert H
    Diabetes Care; 1980; 3(2):309-13. PubMed ID: 6993145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal delivery of insulin by a portable microinfusion pump.
    Eaton RP; Friedman NM; Spencerr WJ
    Metabolism; 1980 Aug; 29(8):699-702. PubMed ID: 6995791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus.
    Dunn FL; Pietri A; Raskin P
    Ann Intern Med; 1981 Oct; 95(4):426-31. PubMed ID: 7025720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of insulin dosage on consecutive days of blood glucose control by an artificial beta-cell in brittle diabetic patients.
    Bruns W; Bombor H; Jutzi E; Ratzmann KP; Schulz B; Abel P; Fischer U
    Diabetes Care; 1983; 6(2):112-7. PubMed ID: 6343014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of intensive supervision in determining the efficacy of insulin pump therapy.
    Nathan DM
    Diabetes Care; 1983; 6(3):295-7. PubMed ID: 6347582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of normal lipid and aminoacid metabolism in diabetic patients treated with a portable insulin-infusion pump.
    Tamborlane WV; Sherwin RS; Genel M; Felig P
    Lancet; 1979 Jun; 1(8129):1258-61. PubMed ID: 87725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels.
    Tamborlane WV; Hintz RL; Bergman M; Genel M; Felig P; Sherwin RS
    N Engl J Med; 1981 Aug; 305(6):303-7. PubMed ID: 7017416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined continuous subcutaneous insulin infusion and multiple subcutaneous injections in type I diabetic patients.
    Schiffrin A; Belmonte M
    Diabetes Care; 1981; 4(6):595-600. PubMed ID: 6751734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.